Europe

Hair loss in AGA – new study by CompLife

Androgenetic Alopecia (AGA) is a progressive hair loss type affecting up to 80% of men and 50% of women. COMPLIFE performed a new study to test the effectiveness of a client’s product on this disease and published it on the “Journal of Cosmetology & Trichology.” Their Methods include: phototrichogram(Anagen, telogen and hair density were estimated in a target area and automatically calculated by TrichoScan® software), global photography assessment , and self assessment questionnaire.

Read the complete study on their website and contact them for further infos.

👉 Find out more about CompLife expertise on the 🥼 clinical testing platform : here

 

CONTACT

www.complifegroup.com

info@complifegroup.com

 

Recent Posts

Skinobs revamps We Are Testing® with a bold new identity

Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…

We Are Testing® at NYSCC Suppliers’ Day 2025

👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…

Pollution, a relevant exposome factor in skin aging and the role of multi-benefit photoprotection via ACTAS

J. Santamaria, Y. Gilaberte, L. Prudkin, J. Piquero-Casals 11 March 2025 Skin aging is a…